---
title: "U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility | PFE Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283337572.md"
description: "U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility | PFE Stock News"
datetime: "2026-04-20T02:45:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283337572.md)
  - [en](https://longbridge.com/en/news/283337572.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283337572.md)
---

# U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility | PFE Stock News

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility | PFE Stock News

### Related Stocks

- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [TBXU.US](https://longbridge.com/en/quote/TBXU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results | PFE Stock News](https://longbridge.com/en/news/287035698.md)
- [Pfizer Inc. $PFE Shares Acquired by Marble Harbor Investment Counsel LLC](https://longbridge.com/en/news/287041763.md)
- [Pfizer Hemophilia Drug Win In Europe Adds Weight To Undervalued Thesis](https://longbridge.com/en/news/286344524.md)
- [How S&P Drug Titan Pfizer Plans To Outdo Its Own $6 Billion Franchise](https://longbridge.com/en/news/287039716.md)
- [European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors | PFE Stock News](https://longbridge.com/en/news/286244385.md)